ELTX vs VNO · $132.3M cap vs rev $921.3M
Elicio Therapeutics Inc. (ELTX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
VNO (VNO) common stock.
ELTX does not have a complete income-statement cache yet.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
ELTX currently screens at market cap $132.3M. VNO currently screens at market cap $0.
Not investment advice. Open the ELTX and VNO stock pages for the full models.
Not investment advice.